- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03041194
Dietary Impact on Urinary pH in Women With Interstitial Cystitis
September 21, 2017 updated by: Rosemary Catanzaro, RD, St. Louis University
Title A Pilot Study to Evaluate the Dietary Impact on Urinary pH in Interstitial Cystitis Pilot Study to Evaluate the Dietary Impact on Urinary pH in Interstitial Cystitis
This is a pilot study on subjects who suffer from Interstitial Cystitis (IC) to assess the dietary affects on urine pH in relation to their symptoms.
The goal of this pilot study is to determine which foods/beverages affect urinary pH and exacerbate patient's symptoms.
Study Overview
Detailed Description
Interstitial cystitis or painful bladder syndrome is a condition that is chronic and often debilitating in nature.
Interstitial cystitis is commonly defined by symptoms of urinary urgency and frequency associated with pelvic pain.
Around one million men and women in the United States and Europe suffer from this condition.
The diagnosis of Interstitial Cystitis is one of exclusion based on cystoscopy findings and clinical symptoms.
Common symptoms of Interstitial Cystitis include urinary frequency, urinary urgency, dysuria, and pain in the lower abdominal region, bladder, vagina, urethra, or in the perinea .
Women between ages 40 and 60 are the most commonly affect by Interstitial Cystitis.
In the Nurses' Healthy Study I and II the prevalence of Interstitial Cystitis was 52-67 individuals out of 100,000.
There is no single cause of Interstitial Cystitis however, there are several known theories to the cause of Interstitial Cystitis.
A popular hypothesis is that a defect in the glycosaminoglycan layer of the bladder epithelium allows leakage and absorption of urinary solutes.
The major solute that is responsible for causing bladder symptoms when the epithelium is injured is potassium.
The long held notion is that patients with Interstitial Cystitis should avoid acidic foods.
This logic is largely based on anecdotal data and questionnaires of foods, beverages and supplements that increase symptoms.
Controversy exists that Interstitial Cystitis diet restricts many more foods than necessary in an attempt to decrease Interstitial Cystitis symptoms.
Current questionnaires-based data suggest eliminating tomatoes, citrus fruits, vitamin C, artificial sweeteners, carbonated and alcoholic beverages, and spicy foods which are thought to exacerbate symptoms, while calcium glycerophosphate and sodium bicarbonate may improve symptoms.
Though the literature review, the investigators did not find any analytical studies that correlated diet with Interstitial Cystitis symptoms or that the ingestion of acidic foods exacerbate Interstitial Cystitis symptoms.
Based on the lack of analytical data and the impact of acidic food on IC symptoms this study is going to evaluate the potential renal acid load and net acid excretion of foods to determine which foods change urinary pH.
Study Type
Observational
Enrollment (Actual)
17
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
female, all backgrounds and races
Description
Inclusion Criteria:
- Women, diagnosed with Interstitial Cystitis or with a presumptive clinical diagnosis of IC
- New IC patients who agree to hydrodistention and cystoscopy, the standard of care for diagnosis of IC
Exclusion Criteria:
- Subjects who are diagnosed with Fibromyalgia Syndrome and subjects that are pregnant.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The impact of urinary pH
Time Frame: 1 year
|
urinary pH.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rosemary Catanzaro, MS RD, St. Louis University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2015
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
January 19, 2017
First Submitted That Met QC Criteria
February 1, 2017
First Posted (Estimate)
February 2, 2017
Study Record Updates
Last Update Posted (Actual)
September 25, 2017
Last Update Submitted That Met QC Criteria
September 21, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25300
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Interstitial Cystitis
-
Asan Medical CenterCompletedChronic Interstitial CystitisKorea, Republic of
-
St. Louis UniversityTerminated
-
Northwell HealthWithdrawnInterstitial CystitisUnited States
-
CAMC Health SystemCompletedInterstitial CystitisUnited States
-
UroGen Pharma Ltd.CompletedInterstitial Cystitis | ICIsrael
-
St. Louis UniversityCompleted
-
Drexel University College of MedicineMedtronicCompleted
-
AllerganTARIS Biomedical, Inc.TerminatedInterstitial CystitisUnited States, Canada
-
ICStudy, LLCAbbottCompleted
Clinical Trials on dietary affects
-
Sakarya UniversityRecruitingPregnant Women | Earthquake | SupportTurkey
-
Ege UniversityCompleted
-
Center of Food and Fermentation TechnologiesCompleted
-
University of ViennaCompletedEndotoxemia | Dietary HabitsAustria
-
Metropolitan CollegeRecruitingOverweight | Overweight and Obesity | AdiposityGreece
-
University of AlbertaCargill; Canada Foundation for Innovation; Nestlé Health Science Spain; Government... and other collaboratorsCompleted
-
Heriot-Watt UniversityUniversity of EdinburghCompleted
-
Bournemouth UniversityEnrolling by invitationDietary Behavior | Free Sugar | Sweet TasteUnited Kingdom
-
University Hospital, ToulouseCompleted
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States